MRNA—(-20%)—reduces 2025 revenue guidance: https://www.accesswire.com/967378/moderna-provides-business-and-pipeline-updates-at-43rd-annual-jp-morgan-healthcare-conference The new 2025 revenue guidance is $1.5-2.5B, down from the $2.5-3.5B 2025 revenue guidance issued in Sep 2024 (#msg-175073473).